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Abbreviation 
 
 
Ab  antibody 
Ag  antigen 
AIDS  acquired immune-deficiency syndrome 
AITL  angioimmunoblastic T cell lymphoma 
APES   aminopropyltriethoxysilane 
AR  antigen retrieval 
BAFF  B cell activating factor of the TNF family 
BLys  B lymphocyte stimulator 
BM  bone marrow 
BSA  bovine serum albumin 
°C  degree Celsius 
CD  cluster differentiation 
CHOP  cyclophophomide, doxorubicin, vincristine, and prednisone 
CR  complement receptor 
DZ  dark zone 
ECOG  Eastern Cooperative Oncology Group 
FDC  follicular dendritic cell 
FFPE  formalin-fixed, paraffin-embedded 
FL  follicular lymphoma 
FLIPI  Follicular Lymphoma International Prognostic Index 
g  gram 
GC  germinal center 
GLSG  German Low-Grade Lymphoma Study Group 
Hb  hemoglobin 
HCl  hydrochloride 
HSA  human serum albumin 
IC  immune complex 
ICAM-1 intercellular adhesion molecule-1 
Ig  immunoglobulin 
IL  interleukin 
l  liter 
LDH  lactate dehydrogenase 
LFA-1  lymphocyte function-associated antigen-1 
LZ  light zone 
  III 
MCP  mitoxantron, chlorambucil, prednisone 
MHC  major histocompatibilty complex class 
MCL  mantle cell lymphoma 
mg  milligram 
NaCl  sodium chloride 
NaOH  sodium hydroxide solution 
NHL  non-Hodgkin lymphoma 
OS  overall survival 
PBS  phosphate-buffered saline 
SD  standard deviation 
TNF  tumor necrosis factor 
TRIS  tris(hydroxymethyl)aminomethane 
TSE  transmissible spongiform encephalitis 
TTF  time-to-treatment failure 
ULN  upper limit of normal 
VCAM-1 vascular cell adhesion molecule-1 
VLA-4  very-late activation antigen 4 
WHO  World Health Organization 
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1 Introduction 
 
 
1.1 Follicular dendritic cells and their functions 
Germinal centers (GC) are sites of antibody affinity maturation within the follicles of 
lymph nodes and other secondary lymphoid organs. They are compartmentalized into 
two major zones: dark and light zones. In the dark zones (DZ) large centroblasts 
rapidly proliferate and undergo somatic mutation of their antibody variable region 
genes. Whereas in the light zones (LZ) small centrocytes compete for binding 
antigen on follicular dendritic cells (FDC) and receive signals from helper T cells to 
survive and differentiate into high affinity antibody secreting plasma cells or memory 
B cells (Allen, Cyster, 2007a). 
Follicular dendritic cells represent a unique population of non-lymphoid accessory 
cells inside germinal centers defined by the following features: (a) they are localized 
within the primary and secondary lymphoid follicles under reactive conditions (Allen, 
Cyster, 2008; Maeda et al., 2002; Park, Choi, 2005; Yoshida et al., 1993); (b) 
morphologically they have long dendritic extensions between B cells and form a 
cellular network by reciprocal connections of their intricately entangled cytoplasmic 
processes with frequent desmosome-like connections to sustain the architecture of 
lymphoid follicles (Kasajima-Akatsuka, Maeda, 2006; Maeda et al., 2002); (c) 
functionally they have the ability to trap and retain antigens for long periods of time in 
the form of immune complexes (IC) (El Shikh et al., 2006); and (d) they express a 
variety of molecules involved in the proliferation and differentiation of lymphocytes, 
especially of B cells, and promote their survival (Allen, Cyster, 2008; El Shikh et al., 
2006; Park, Choi, 2005).  
The cellular interactions between FDC and germinal center B cells are carried out in 
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co-operation with a variety of molecules (Figure 1). The first group of molecules 
comprises pairs of adhesion molecules; intercellular adhesion molecule-1 (ICAM-1) 
(CD54) on FDC with lymphocyte function-associated angiten-1 (LFA-1) on B cells 
and vascular cell adhesion molecule-1 (VCAM-1) on FDC with very-late activation 
antigen 4 (VLA-4) on B cells. They enhance cell-cell contacts and thus facilitate the 
anti-apoptotic functions of FDC (Park, Choi, 2005). The second group comprises anti-
apoptotic molecules produced by FDC such as tumor necrosis factor (TNF) 
superfamily ligand BAFF (B cell activating factor of the TNF family), also known as 
BLys (B lymphocyte stimulator). They are required for B cell maturation and prevent 
apoptosis of GC B cells (Park, Choi, 2005; Schiemann et al., 2001; Thompson et al., 
2000). The third group of molecules comprises those related to the proliferation of 
GC B cells such as 8D6 and membrane-bound interleukin (IL)-15 (Park et al., 2004; 
Park, Choi, 2005). Another important functional group of molecules include those 
involved in immune complex display. FDC do not internalize, process and present 
antigen in the context of major histocompatibilty complex class II (MHC II), but 
present intact antigen-antibody (Ag-Ab) in the form of immune complexes on their 
surfaces. They are held by Fc binding receptors such as CD23 or complement 
receptors such as CD21 and CD 35 (Allen, Cyster, 2008; Park, Choi, 2005). 
 
The dark and light zones of GC are two different compartments with regard to the 
proliferation and differentiation of GC B cells with its specific microenvironment. In the 
dark zone, rapidly dividing centroblasts produce non-proliferating centrocytes that are 
thought to migrate to the light zone of the germinal center and either differentiate into 
memory B cells or antibody-secreting cells or undergo apoptotic cell death 
(Freedman et al., 1995; Rademakers, 1992; Schwickert et al., 2007). In accordance 
with the function of the GC compartments, there is a different distribution pattern of 
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distinct FDC subtypes in the light and dark zones of GC (Li, Choi, 2002). FDC are 
present at a much higher density in the light zone than in the dark zone (less than 2% 
of the cell population) (Freedman et al., 1995; Yoshida et al., 1993). And the light 
zone FDC strongly express Fc fragment-binding proteins such as CD23 and CD32 
and complement receptors such as CD21 (CR2) and CD35 (CR1) in comparison to 
the dark zone FDC, suggesting functional and phenotypical heterogeneity of FDC in 
GC (Yoshida et al., 1993). 
 
In the GC, where the major events of anamnestic humoral immune responses are 
thought to take place, the interaction between FDC and B cells, especially the ability 
of FDC to present immune complexes to GC B cells, is assumed to play a pivotal role 
in the selection of antigen-specific B cells and their clonal expansion (Kasajima-
Akatsuka, Maeda, 2006; Allen et al., 2007a; Allen et al., 2007b). Even though the 
fundamental biology and behavior of FDC have not yet been fully defined, it seems 
very likely that the integrity of FDC networks not only significantly influences GC 
reactions, but also plays a central role in the pathogenesis of several diseases e.g. 
lymphoma, acquired immune-deficiency syndrome (AIDS), transmissible spongiform 
encephalitis (TSE) and autoimmune diseases such as rheumatoid arthritis (Li, Choi, 
2002;  Kosco-Vilbois, 2002; Park, Choi, 2005). Thus, it gives us rise to study more 
closely the altering FDC function and its consequences. 
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Figure 1: Interaction between FDC and GC B cell. FDC interact with GC B cells via 
several mechanisms including adhesion molecules such as ICAM-1 and VCAM-1, B 
cell anti-apoptotic TNF superfamily ligand BAFF, Fc binding proteins such as CD23 
and complement receptors such as CD 21 for immune complex presentation and 8D6 
and membrane-bound interleukin (IL)-15 for B cell proliferation.  
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1.2 Follicular dendritic cells in non-Hodgkin lymphomas 
FDC form a three-dimensional network in the GC, a dynamic microenvironment 
where antigen-activated B cells expand and undergo events associated with antibody 
affinity maturation and the majority of B cell lymphomas originate from (Allen, Cyster, 
2008; Küppers et al., 1999; Park, Choi, 2005). Because of the intimate relationship 
between FDC and B cells, FDC is expected to affect B cells and even play a role in 
pathogenesis of neoplastic lymphoproliferations in yet uncertain way (Bagdi et al., 
2001). In certain B cell non-Hodgkin lymphomas (NHL) FDC can be detected among 
the reactive bystander cells of the tumor (Bagdi et al., 2001). Whereas in marginal 
zone lymphomas FDC are considered to represent remnants of GC that have been 
colonized by lymphoma cells, it has been suggested that FDC in mantle cell 
lymphoma (MCL), follicular lymphoma (FL) and angioimmunoblastic T cell lymphoma 
(AITL) are newly generated and have proliferated during lymphoma growth and 
expansion (Swerdlow et al., 2008).  
Structural alterations in the network of FDC such as atypical shape or expansion are 
also frequently found in malignant lymphoma and can be useful adjunct in the 
diagnostic immunophenotyping of the malignant lymphomas (Bagdi et al., 2001). In 
FL the abnormal follicles demonstrate dense, sharply defined and expanded FDC 
networks reminiscent of those seen in the normal germinal centers. They are 
exclusively found within malignant follicles and absent in the interfollicular lymphoma 
compartment as well as in diffusely growing FL (Bagdi et al., 2001; Klapper et al., 
2007). In MCL loosely arranged, weakly developed FDC network in nodular or diffuse 
patterns are observed (Bagdi et al., 2001, Schrader et al., 2006). And the most 
common morphological subtype of AITL (pattern 3) shows a prominent diffuse 
proliferation of FDC network with frequent incorporation of proliferating postcapillary 
venules, an important hallmark of the disease since this pattern has not been found 
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in any other T cell lymphomas hence facilitating the differential diagnosis (Attygalle et 
al., 2002; Bagdi et al., 2001).   
The immunophenotype of FDC in reactive and neoplastic lymphoid tissues has been 
characterized, and reduced expression of markers of mature FDC was noted in FL 
and MCL (Bagdi et al., 2001; Chang et al., 2003). Recently, gene expression profiling, 
a quantitative method, has revealed that the expression of FDC-related genes is 
associated with the clinical course in follicular lymphoma (Dave et al., 2004). Another 
study has shown that the growth pattern and distribution of FDC in mantle cell 
lymphoma are associated with the clinical outcome (Schrader et al., 2006). Thus, 
further study of the altering FDC function may provide invaluable information for 
understanding and classifying malignant lymphomas and a target for clinically 
manipulating disease.  
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1.3 Aim of the study 
Inspired by the recent findings about the accessory functions of FDC and the close 
relationship between FDC and B cells, we decided to study the different 
immunophenotypes of FDC and its morphological and clinical correlation. Since FDC 
are large cells with long dendritic extensions and hardly detectable cell bodies, the 
quantification of the extent of FDC networks or the immunophenotype of FDC using 
conventional staining and light microscopy is highly observer-dependent. Thus, we 
developed a method employing multicolor immunofluorescence staining followed by 
digital image analysis to detect FDC with its dendritic extensions.  
The aims of our study were:  
1. To characterize differences and similarities between the FDC 
immunophenotypes in the functional compartments of the reactive GC,  
2. to characterize differences and similarities between the FDC 
immunophenotypes in NHL which contained FDC as reactive bystander cells, 
namely FL, MCL and AILT, and compare them with those in GC in order to 
gain insights into a possible role of FDC in lymphoma development and  
3. to quantify the extent of FDC networks precisely in an example of NHL, 
namely FL, and to correlate the extent of FDC networks with clinical outcome 
in FL. 
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2 Materials and methods 
 
 
2.1 Case selection 
Formalin-fixed, paraffin-embedded (FFPE) tissue samples from representative 
examples of tonsils (n = 10), follicular lymphoma grades 1 or 2 (n = 5), mantle cell 
lymphoma, classical type (n = 7), and angioimmunoblastic T cell lymphoma (n = 5) 
were selected from the files of the Lymph Node Registry in Kiel. The lymphoma 
biopsy specimens were anonymized according to the ethical guidelines of the 
Medical Faculty of the University of Kiel (institutional review board) for retrospective 
analysis of archived material. All cases were classified according to the WHO 
classification by means of morphological examination and immunophenotyping on 
paraffin sections (Swerdlow et al., 2008).  
For clinical correlation, 108 formalin-fixed, paraffin-embedded lymph node biopsy 
specimens were analyzed from the patients with advanced stage follicular lymphoma 
recruited between May 1996 and December 2000 for the trial “CHOP versus MCP” of 
the German Low-Grade Lymphoma Study Group (GLSG) from the reference 
pathology departments in Kiel, Würzburg, Frankfurt and Lübeck (Nickenig et al., 
2006). The admission criteria to the study were the age >18 and an untreated 
follicular lymphoma in Ann-Arbor-Stage III or IV. Furthermore, the necessity of a 
therapy must exist, characterized by at least one of the following criteria: 1. B-
symptoms, 2. hematopoietic insufficiency, 3. rapid progress of the disease, 4. Bulk-
formation. 
In this study only primary biopsies obtained before any treatment for advanced stage 
FL were analyzed. All studies were performed on full sections of the biopsy specimen. 
For analysis of patient material from the GLSG trials, informed consent of the patients 
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was available. After the randomization, all of the patients were either assigned to 
CHOP (cyclophophomide, doxorubicin, vincristine and prednisone) or MCP 
(mitoxantron, chlorambucil and prednisone) therapy. 
 
Parameter Value No. % % of all study patients* 
Age ≥ 60 29 21 26 
Sex Male 60 44 50 
Stage (n = 136) IV 94 69 71 
B-symptoms (n = 136) present 53 39 40 
Spleen involvement (n = 126) present 35 28 35 
BM involvement present 91 66 67 
extranodal sites > 1 19 14 23 
Involved nodal areas (n = 136) > 4 104 76 68 
ECOG performance status > 1 7 5 10 
LDH > ULN 40 29 30 
Hb (n = 135) < 120 g/l 20 15 19 
FLIPI (n = 135) Low 21 16 14 
 Intermediate 57 42 40 
 High 57 42 46 
* All patients with advanced follicular lymphoma registered to the trial 
Table 1: Clinical baseline characteristics of the population studied in this report (n = 
137) compared with all patients with advanced stage follicular lymphoma registered 
in the trial (n = 538). 
Abbreviations: BM = bone marrow, ECOG = Eastern Cooperative Oncology Group, LDH = lactate 
dehydrogenase, Hb = hemoglobin, FLIPI = Follicular Lymphoma International Prognostic Index, ULN = 
upper limit of normal. 
 
2.2 Fluorescence immunohistochemistry 
2.2.1 Preparation of microscopic sections 
Four-micrometer thick sections of the tonsil or lymph node formalin-fixed and 
paraffin-embedded tissues were mounted on 3-aminopropyltriethoxy silane (APES)-
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coated slides and subsequently incubated at 37˚C overnight. They were 
deparaffinized in xylol for 10 minutes and rehydrated in a series of degraded ethanol 
(100%-100%-100%-96%-96%-70%).  
Antigen retrieval:  
Because of the superior preservation of morphology, formalin-fixed, paraffin-
embedded tissue remains the medium of choice for most clinical and research 
studies. However, the fixation in formalin can result in the loss of immunoreactivity of 
the antigens (Key, 2006). To detect the reactive epitopes in formaldehyde-fixed 
material previous antigen retrieval (AR) is required. Antigen retrieval or antigen 
recovery is a technique performed to expose antigens which have become masked 
by the tissue fixation process. There are various protocols available, such as heat 
exposure or enzyme application. In this study, several antigen retrieval methods were 
tested to obtain reliable staining for each marker. The slides with tissue sections to be 
used for double staining were boiled in citric acid buffer at pH 3.0 for 4 minutes in a 
pressure cooker. This procedure yielded staining patterns for each antibody that were 
comparable to single staining. The extent of FDC networks in study samples to be 
used for clinical correlation was assessed by single staining using Ki-M4p or CD23. 
The epitopes for Ki-M4p were unmasked by digesting the sections with protease 
XXIV at pH 7.5 for 20 minutes, for CD23, the previous protocol with citric acid buffer 
was applied. After the antigen retrieval, the slides were transferred without delay to 
cold running water for washing and then immersed in phosphate-buffered saline 
(PBS) buffer.  
 
2.2.2 Fluorescence immunohistochemistry 
Pan-FDC marker, Ki-M4p 
A number of monoclonal antibodies that detect FDC have been developed to define 
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their unique immunophenotype. Some of them, such as X-11 and 12B1 are known to 
detect FDC located in the light zone of GC (LZ pattern) whereas anti-S100α is only 
reactive for FDC located in the dark zone of GC (DZ pattern). In this study, we have 
applied Ki-M4p, a mouse monoclonal antibody detecting FDC network through the 
whole of the lymphoid follicle, as pan-FDC marker (Maeda et al, 2002; Parwaresch et 
al., 1983).  
 
Primary antibodies such as rabbit anti-human CD23, rabbit anti-human CD35 and 
goat anti-human CD54 were diluted 1:50 in 1%-bovine serum albumin (BSA), the 
matching fluorescent secondary antibodies were diluted 1:50 in 1%-human serum 
albumin (HSA). Ki-M4p was applied as undiluted cell culture supernatant from our 
laboratory (Parwaresch et al., 1983). 
The staining protocols were carefully established to avoid non-specific staining of 
cells other than FDC. The incubation of the first primary antibodies such as Ki-M4p or 
CD23 was performed overnight in a moisturized chamber at room temperature. 
Matching fluorescence-labeled secondary antibodies (Alexa Fluor 488 or Alexa Fluor 
594; Invitrogen, Carlsbad, CA, USA, diluted 1:100) were incubated on the sections in 
a moisturized chamber for 60 minutes at room temperature. Afterwards, the sections 
were thoroughly washed with PBS three to four times and covered manually using 
fluorescent mounting medium.  
For double staining, Ki-M4p was combined with one of the following antibodies: rabbit 
anti-human CD23 (Neomarkers, Freemont, CA, USA), rabbit anti-human CD35 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) or goat anti-human CD54 (R&D 
Systems, Minneapolis, MN, USA).   
Second primary antibodies such as CD23, CD35 and CD54 were then incubated on 
the already with Ki-M4p stained sections in a moisturized chamber for 60 minutes at 
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room temperature. Afterwards, the sections were thoroughly washed with PBS buffer 
three to four times. Matching fluorescent secondary antibodies (Alexa Fluor 594 anti-
rabbit IgG for CD23 and CD35; Alexa Fluor 594 anti-goat IgG for CD54) were then 
incubated on the sections in a moisturized chamber for 60 minutes at room 
temperature. Afterwards, the sections were thoroughly washed with PBS buffer four 
to five times. The sections were covered manually applying fluorescent mounting 
medium and the cover glass was encircled with a transparent nail polish to protect 
the fluorescent dye. Subsequently, the sections were preserved in a refrigerator. 
 
2.2.3 Antibodies, chemicals and utensils 
Antibodies Sources 
Mouse anti-human Ki-M4P Department of Hematopathology, University of 
Kiel, Germany 
Rabbit anti-human CD23 (SP23) NeoMarkers, No. RM-9123-S 
Rabbit anti-human CD35 (H-300) Santa Cruz Biotechnology,  
No. sc-20924 
Goat anti-human ICAM-1/CD54 R&D Systems, No. BBA17 
Alexa Fluor 488 F(ab’)2 fragment of goat anti-
mouse IgG (H+L) 
Invitrogen, No. A11017 
Alexa Fluor 488 donkey anti-rabbit IgG (H+L) Invitrogen, No. A21206 
Alexa Fluor 594 donkey anti-rabbit IgG (H+L) Invitrogen, No. A21207 
Alexa Fluor 594 donkey anti-goat IgG (H+L) Invitrogen, No. A11058 
Table 2: Antibodies and their sources 
 
Buffers Fabrication formula 
Citrate buffer 2,1 g Citric acid-monohydrate in 1 l distilled water, titrated with NaOH (2 mol/l) and 
HCl (2 mol/l) until either pH 3 is reached 
TBS buffer 9,0 g TRIS- Base , 68,5 g TRIS-HCl, 87,8 g NaCl in 10 l distilled water 
Protease 0,02 g Protease XXIV (Sigma, P-8038) in 200 ml TBS-buffer, pH 7,5 at 37˚C 
PBS buffer 100 ml of 10x concentrated PBS diluted with 900 ml of distilled water  
Table 3: Buffers, solutions and fabrication formula 
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Chemicals Manufacturer 
Bovine serum albumin Sigma, No. A-4503 
Citric acid-monohydrate Merck, No. 1.00244 
Distilled water DeltaSelect, No. 23705-12A 
Ethanol Merck, No. 1.00983 
Fluorescent mounting medium DakoCytoformation, No. S3023 
Hydrochloride (HCl, 2 Mol) Merck, No. 1.09063  
Nail polish  Essence, multi dimension 01 
PBS 10x, pH7,2, CaCl2, MgCl2 GIBCO, No. 70013-016 
Protease XXIV Sigma, No. P-8038 
Sodium chloride (NaCl) Walter & Co 
Sodim hydroxide solution (NaOH, 2 Mol) Merck, No. 1.09136  
TRIS base Sigma, No. T-1503 
TRIS HCl Sigma, No. T-3253 
Xylol Merck, No. 1.08681 
Table 4: Chemicals and their sources 
 
Human serum albumin was available by courtesy of the Institute of Transfusion 
Medicine, University of Kiel. It was frozen in 1ml-aliquots at – 20˚C after inactivation 
for 30 minutes at 65 ˚C in water bath. 
 
Utensils Manufacturer 
Axioplan 2 imaging and Axiophot 2 
Universalmikroscope 
ZEISS 
Cover glass 24 x 50mm Menzel Gläser 
Glass slide Marienfeld, No. 1000200 
Glove Nitra-Tex Ansell, No. 4400013/70052 
Glove Peha-Soft Hartmann, No. 942162 
Incubator Memmert 
Lamp N HBO 100 ZEISS, No. 000000 1007-980 
ZEISS, No. 000000 1002-928 
Mercury vapor short arc lamp OSRAM, No. 380301-9350 
Microscopic slide HistoBond,  
PES-coated, 76x26x1mm 
Marienfeld, No. 0810000 
Objective: Plan-NEOFluar 20x/0,50 ZEISS 
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Pipets  Eppendorf 
Pressure cooker TEFAL 
Sliding microtome Reichert-Jung, No. Hn 40 
SPOT slider - RT Realtime Visitron Systems GmbH, No. 998258 
Water bath  Köttermann 
Table 5: Utensils and their sources 
 
2.3 Analytical methods 
2.3.1 Digital image analysis 
Software Manufacturer 
Adobe Photoshop 7.0 Adobe Systems 
analySIS FIVE Olympus Soft Imaging System 
MetaView Imaging Software Visitron Systems GmbH, No. 5826 
GraphPad prism Graph Pad Prism Software Inc. 
Table 6: Software and their sources 
 
In every section, five independent areas containing a GC in tonsils, a malignant 
follicle in FL or areas with FDC networks in MCL or AITL were selected and 
photographed at a magnification of x 200 (Axioscope 40 microscope Zeiss, Jena, 
Germany, equipped with an Image View Camera, Soft Imaging Systems Olympus, 
Hamburg, Germany and MetaView Imaging Software, Visitron Systems GmbH, 
Puchheim, Germany) at room temperature. To ensure that areas with FDC were 
analyzed exclusively, the GC or FDC-containing areas were cut out of the pictures by 
means of Adobe Photoshop 7.0 and pasted into a separate blank image with a white 
background. The dark zone of the GC can be easily identified because of the 
reduced FDC network and was isolated from the rest of the GC in the same manner. 
All images were analyzed using the software analySIS (Soft Imaging Systems 
Olympus, Hamburg, Germany). For this purpose, the area that stained positively for 
each or both antibodies was measured in square pixels. The percentage of all FDC 
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co-expressing CD23, CD35 or CD54, as assessed by the pan-FDC marker Ki-M4p, 
was calculated (% co-expression). All values are expressed as means with the 
standard deviation (SD) indicated. 
For correlation of FDC networks with clinical outcome in FL, we looked for a measure 
of the density of the FDC network within the follicles. For this, the area covered by 
the FDC within 5 representative malignant follicles was quantified analogous to the 
double staining and expressed as FDC covered area in relation to the whole area of 
the neoplastic follicle.  
 
Phase analysis (Soft Imaging System GmbH, 2002): 
Phase analysis of analySIS is a quantitative evaluation of area with regard to each 
separate color phase. The definition of numerous color ranges which are assigned to 
individual phases is a prerequisite. 
How to conduct phase analysis: 
1) Load a Photoshop image (from the step 2.3.1) you wish to analyze into the active 
image buffer. 
2) Select the Image>Set Color Thresholds… command to define the color ranges for 
the separate phases. 
3) Delete all phases already defined except one. To do this, select an entry from the 
Phase list and click the Delete button. As soon as only one phase is defined the 
Delete button will become inactive. 
4) Define the phase using the Include Pixel or Exclude Pixel buttons.  
5) Click the New button to add a second phase. A new entry will be added to the 
Phase list. The new phase will automatically be colored in a color not yet taken. If you 
like, you can alter the color by selecting one from the Color palette. The newly-added 
phase will now be activated.  
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6) Define the color range for the second, third, fourth etc. phases. 
7) Confirm the new threshold setting by clicking on OK. 
8) Select the Measure > Phase Analysis command. Your image analysis program will 
create a measurement sheet showing the absolute area and proportional area (in %) 
of all the phases. Save the measurement sheet as an appropriate name. 
9) Select the Measure > Phase Color Coding command to generate a false-color 
image based on the color phases defined. The color of the phase will correspond to 
the header color in the measurement sheet. 
10) Now load the next image you wish to analyze. 
11) Select the Measure > Phase Analysis command. The thresholds currently set are 
still valid. Phase analysis will be conducted based on these thresholds. The 
measurement values will be appended to the existing sheet. 
 
2.3.2 Statistical analysis 
Co-expression was compared by means of t-tests using GraphPad prism (Graph Pad 
Prism Software Inc., San Diego, CA, USA). To assess the prognostic impact of FDC 
networks on overall survival (OS) and time-to-treatment failure (TTF), Kaplan-Meier 
curves were calculated and group comparisons were done by means of the log-rank 
test. The prognostic impact of numerical parameters was assessed by univariate and 
adjusted Cox regression. 
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Figure 2: Representative examples of fluorescent double staining using the pan-FDC 
marker Ki-M4p (A, single staining), CD23 (B, single staining), Ki-M4p and CD23 (C, 
double staining) and quantitative image analysis “Phase analysis” (D) with software 
analySIS to assess the extent of co-expression. 
 
 
 
 
 
(B) CD23 
(C) CD23+Ki-M4p (D) Phase Analysis 
(A) Ki-M4p 
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3 Results 
 
 
3.1 Morphological results 
Aim 1: Characterization of FDC immunophenotypes in reactive GC 
GC of lymphoid follicles contain two different microenvironmental zones: the dark 
zone and the light zone. The dark zone at the base of the follicular center contains 
tightly packed centroblasts whereas the light zone at the apex contains non-dividing 
centrocytes. The follicular dendritic cell network extends throughout the GC, but is 
much sparser in the dark than in the light zones (Freedman et al., 1995; Carbone et 
al., 2009). In accordance with the function of the GC compartments and the different 
distribution pattern of FDC, heterogeneity of FDC immunophenotypes in reactive GC 
is expected (Li, Choi, 2002). Here, we studied the FDC immunophenotypes in the 
dark zone, light zone and in the whole GC applying pan-FDC marker, Ki-M4p and 
other FDC functional groups such as CD23, CD35 and CD54. As a control of our 
fluorescence double staining method for quantifying FDC protein expression, five GC 
were analyzed in each of 10 hyperplastic tonsils. The dark zone of the GC was 
analyzed separately and compared to the entire GC, which is dominated by the 
dense FDC networks of the light zone. Since the light zone contained more FDC than 
the dark zone as shown in Figure 3, the values for the whole follicle resembled 
mainly light zone FDC. In all analyses, the area detected by the marker Ki-M4p was 
larger than the area staining for CD23, CD35 or CD54, indicating that Ki-M4p is 
useful as a pan-FDC marker (Parwaresch et al., 1983). As shown in Figure 4 and in 
Table 7, the dark zone FDC displayed reduced co-expression of the Fc-
receptor/CD23 (8.5%, SD 5.2), complement receptor 1/CD35 (20.2%, SD 6.9) and 
ICAM-1 (intercellular adhesion molecule-1)/CD54 (19.0%, SD 6.8), compared to the 
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FDC in the entire follicle (CD23: 32.1%, SD 10.8; CD35: 38.9%, SD 15.7; CD54: 
37.2%, SD 10.8), and the differences were statistically significant (P < 0.0001, P = 
0.0029 and P =  0.0003, respectively, t-test). These data are in line with the 
published literature, which are based mainly on the analysis of mouse GC and 
confirm our method for detecting protein expression semi-quantitatively in FDC 
(Bagdi et al., 2001; Chang et al., 2003; Yoshida et al., 1993). 
 
 
 
 
Figure 3: Representative example of fluorescence double staining using the pan-
FDC marker Ki-M4p (green) and CD23 (red) in a reactive germinal center (GC). In 
the light zone (LZ), FDC are present in a much higher density than in the dark zone 
(DZ). 
 
DZ 
Reactive GC 
LZ 
DZ 
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Figure 4: Quantitative analysis of co-expression of CD23, CD35 and CD54 on 
follicular dendritic cells (FDC) in the entire germinal center (total GC) or the dark zone 
(DZ) in tonsils. The FDC in the dark zone (DZ) of the GC display a reduced 
expression of the Fc-receptor (CD23), complement receptor 1 (CD35) and adhesion 
molecule ICAM-1 (CD54), compared to the FDC in the whole follicle (total GC), which 
is dominated by the light zone FDC. P-values were obtained using t-tests. Horizontal 
bars indicate the mean. 
 
 Ki-M4p/CD23 Ki-M4p/CD35 Ki-M4p/CD54 
Total reactive GC 32.1 (SD 10.8) 38.9 (SD 15.7) 37.2 (SD10.8) 
DZ of reactive GC 8.5 (SD 5.2) 20.2 (SD 6.9) 19.0 (SD 6.8) 
Table 7: Co-expression on FDC. All values as % co-expressing FDC area. GC = 
germinal center, DZ = dark zone, SD = standard deviation. 
 
Aim 2: Characterization of FDC immunophenotypes in NHL 
Staining pattern 
The staining pattern of FDC networks in FL, MCL and AITL showed considerable 
difference regarding the extent, distribution and morphology. Figure 6 shows 
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representative examples of the staining pattern. In FL, the FDC network was dense 
and sharply defined inside the abnormal follicles reminiscent of those seen in the 
normal GC. Furthermore, FDC network was absent in the interfollicular lymphoma 
compartment. In MCL, FDC network was very weakly developed and of either small 
nodular or diffuse pattern which made locating the FDC network for our study difficult. 
Finally, in AITL, the FDC networks showed a diffusely expanding feature with 
irregular shape with frequent incorporation of postcapillary venules. These data were 
in line with the published literature (Attygalle et al., 2002; Bagdi et al., 2001; Klapper 
et al., 2007; Schrader et al., 2006). 
 
Membrane-bound FDC functional groups 
Compared with the FDC in the GC as a whole, the FDC in FL, AITL and MCL 
displayed significantly reduced expression of CD23 (FL: P = 0.0012, AITL: P = 
0.0214 and MCL: P = 0.0418), CD35 (FL: P = 0.0067, AITL: P = 0.002, and MCL: P = 
0.001) and CD54 (FL: P = 0.0017, AITL: P = 0.0003 and MCL: P = 0.0007). Figure 5 
and Table 8 provide a summary of all data. The level of co-expression of the above 
mentioned markers in the lymphomas was comparable to that of the FDC in the dark 
zone of the GC (Table 8), with the exception of CD23, which was expressed at 
significantly higher levels in the FDC of AITL and MCL than in the dark zone of the 
GC (P = 0.0031, and P = 0.0054, respectively). 
 
  22 
 
Figure 5: Quantitative analysis of co-expression of CD23 (A), CD35 (B) and CD54 
(C) on FDC in the entire germinal center (total GC), follicular lymphoma (FL), 
angioimmunoblastic T cell lymphoma (AITL) and mantle cell lymphoma (MCL). FDC 
in FL, AITL and MCL display quantitatively reduced expression of CD23, CD35 and 
CD54 compared to the FDC in the entire GC. The levels of CD35 and CD54 co-
expression in the lymphomas are comparable with the FDC in the dark zone of the 
GC (P-values not significant using a t-test, data shown in Table 8). P-values were 
obtained using t-tests. Horizontal bars indicate the mean. 
 
 Ki-M4p/CD23 Ki-M4p/CD35 Ki-M4p/CD54 
Total reactive GC 32.1 (SD 10.8) 38.9 (SD 15.7) 37.2 (SD10.8) 
DZ reactive GC 8.5 (SD 5.2) 20.2 (SD 6.9) 19.0 (SD 6.8) 
FL 9.5 (SD 8.1) 14.9 (SD 6.9) 17.0 (SD 4.9) 
AITL 18.6 (SD 4.9) 9.2 (SD 9.7) 12.4 (SD 3.9) 
MCL 20.6 (SD 10.1) 12.7 (SD 7.4) 18.6 (SD 7.4) 
Table 8: Co-expression on FDC. All values as % co-expressing FDC area. GC = 
germinal center, DZ = dark zone, FL = follicular lymphoma, AITL = 
angioimmunoblastic T cell lymphoma, MCL = mantle cell lymphoma, SD = standard 
deviation. 
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Figure 6: Representative examples of fluorescence double staining using the pan-
FDC marker Ki-M4p (green) and co-expression (yellow) of CD23 (red), CD35 (red) 
and CD54 (red) in representative examples of follicular lymphoma (FL), 
angioimmunoblastic T cell lymphoma (AITL) and mantle cell lymphoma (MCL). 
 
 
 
 
 
 
 
 
FL 
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3.2 Clinical results 
Aim 3: Correlation between the extent of FDC networks and clinical outcome in 
follicular lymphoma 
Follicular lymphoma, the second most common subtype of NHL after diffuse large B 
cell lymphoma, is an indolent lymphoma characterized by long median overall 
survival, even without therapy, and rare spontaneous remissions. However, a 
considerable number of patients die within the first two years after the onset of the 
disease (Álvaro et al., 2006; Klapper et al., 2007). In the current work, we quantified 
the extent of FDC networks in the malignant follicles of primary biopsies obtained 
from patients with advanced stage FL recruited for the prospective randomized trial 
“CHOP versus MCP” of the German Low-Grade Lymphoma Study Group (GLSG) 
before any treatment has begun. We detected the FDC networks using single 
staining for the pan-FDC marker Ki-M4p or CD23. The area detected by the staining 
varied throughout the cohort examined for Ki-M4p (median 7.33 square pixels, 
minimum 2.52, maximum 24.48, n = 102) and CD23 (median 10.86 square pixels, 
minimum 2.70, maximum 51.50, n = 81). The prognostic impact of numerical 
parameters was assessed by univariate and adjusted Cox regression. However, 
there was no association between the extent of the FDC network measured by Ki-
M4p or CD23 with clinical outcome, as measured by time-to-treatment failure (TTF) 
and overall survival (OS) (univariate and adjusted Cox regression, data shown in 
Table 9). 
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 (A) 
Univariate Cox Regression 
Variable total Hazard ratio hrlowercl hruppercl probchisq 
KiM4p 100 0.7 0.4 1.3 0.26 
CD23 79 0.8 0.6 1.1 0.13 
Adjusted Cox Regression 
Parameter variable Hazard ratio hrlowercl hruppercl Probchisq 
KiM4p  1.0 0.9 1.0 0.33 
 Age 1.0 1.0 1.0 0.58 
 Lnreg 1.1 1.0 1.2 0.13 
 ecogrisk 1.3 0.4 4.9 0.66 
 Hb 1.0 1.0 1.0 0.07 
 LDH 1.4 0.8 2.4 0.18 
CD23  0.8 0.6 1.0 0.09 
 Age 1.0 1.0 1.0 0.59 
 Lnreg 1.1 1.0 1.2 0.07 
 ecogrisk 0.9 0.2 5.4 0.95 
 Hb 1.0 1.0 1.0 0.04 
 LDH 1.5 0.8 2.8 0.17 
(B) 
Univariate Cox Regression 
Variable Total Hazard ratio hrlowercl hruppercl Probchisq 
KiM4p 102 1.0 0.9 1.1 0.80 
CD23 81 1.0 0.6 1.7 0.97 
Adjusted Cox Regression 
parameter variable Hazard ratio hrlowercl hruppercl probchisq 
KiM4p  1.0 0.9 1.1 0.94 
 age 1.0 0.9 1.0 0.50 
 lnreg 0.9 0.8 1.1 0.40 
 ecogrisk 3.1 0.6 17.2 0.20 
 Hb 1.0 0.9 1.0 0.17 
 LDH 2.2 1.1 4.5 0.02 
CD23  1.0 0.6 1.7 0.99 
 Age 1.0 0.9 1.0 0.69 
 Lnreg 0.9 0.7 1.1 0.23 
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 ecogrisk 3.6 0.6 20.1 0.15 
 Hb 1.0 0.9 1.0 0.16 
 LDH 2.0 1.0 4.2 0.06 
Table 9: Prognostic relevance of the extent of FDC networks in malignant follicles of 
follicular lymphoma. There was no association between the extent of the FDC 
networks measured by Ki-M4p or CD23 with clinical outcome, as measured by time-
to-treatment failure (TTF) (A) and overall survival (OS) (B) estimated by univariate 
and adjusted Cox regression model. 
Abbreviations: hrlowercl = hazard ratio lower confidence limit, hruppercl = hazard ratio upper 
confidence limit, probchisq = probability of chi squared distribution, lnreg = lymph node region, 
ecogrisk = Eastern Cooperative Oncology Group risk/performance status, Hb = hemoglobin, LDH = 
lactate dehydrogenase. 
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4 Discussion 
 
 
FDC and their function 
Germinal centers are the main sites where high affinity antibody secreting plasma 
cells and memory B cells generate from. It is organized into two major zones, the 
dark and light zone (Allen, Cyster, 2007a). The dark zones contain large centroblasts 
that rapidly proliferate and undergo somatic mutation of their antibody variable region 
genes. Whereas in the light zones small centrocytes compete for binding antigen on 
follicular dendritic cells and receive signals from helper T cells to survive and 
differentiate (Allen, Cyster, 2007a). 
FDC represent a unique population of non-lymphoid accessory cells localized within 
the germinal centers of primary and secondary lymphoid follicles under reactive 
conditions (Allen, Cyster, 2008; Maeda et al., 2002; Park, Choi, 2005). They form a 
cellular network with long dendritic extension between GC B cells, trap and present 
antigens in form of immune complexes and interact with B cells with a variety of 
molecules involved in the proliferation, differentiation and survival of B cells (Allen, 
Cyster, 2008; El Shikh et al., 2006; Kasajima-Akatsuka, Maeda, 2006; Maeda et al., 
2002; Park, Choi, 2005). The adhesion molecules such as CD44, CD54 and CD166 
enhance B cell adherence to FDC, Fc binding receptors (CD23, CD32) and 
complement receptors (CD21, CD35) present immune complexes to B cells (Allen, 
Cyster, 2008; Park, Choi, 2005). In addition to that, FDC express 8D6 and 
membrane-bound IL-15 which stimulate B cell proliferation and transmit anti-
apoptotic signals to proliferating B cells via BAFF/BLys and Notch ligands DII1 and 
Jg6 (Hase et al., 2004; Park et al., 2004; Park, Choi, 2005; Yoon et al., 2009). In 
accordance with the function of GC, which consists of a dark zone where densely 
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packed centroblasts rapidly proliferate and a light zone comprised of non-proliferating 
centrocytes that either differentiate or undergo apoptosis, FDC also show a 
differentiated distribution pattern and immunophenotype within the GC (Freedman et 
al., 1995; Li, Choi, 2002). The FDC in the light zone are predominantly involved in 
immune complex presentation and selection of B cells that produce high-affinity 
immunoglobulin directed against the antigen presented by the FDC. Thus, FDC are 
present at a much higher density in the light zone than in the dark zone and the light 
zone FDC strongly express molecules involved in immune complex display such as 
Fc fragment-binding proteins (CD23 and CD32) and complement receptors (CD21 
and CD35) (Freedman et al., 1995; Yoshida et al., 1993). FDC in the dark zone is 
sparse and their function is less clearly defined, however the reduced expression of 
CD23 and CD21 on FDC in the dark zone indicate that immune complex presentation 
and B cell selection is not the predominant function of the FDC in the dark zone, 
suggesting functional and phenotypical heterogeneity of FDC within GC (Yoshida et 
al., 1993). Instead, FDC in the dark zone might provide anti-apoptotic and growth 
factors creating an ideal microenvironment for the rapidly dividing centroblasts 
supporting both their proliferation and survival (Choe et al., 2000; Park, Choi, 2005). 
GC development, the site of memory B cells and initial plasma cell differentiation in 
the secondary antibody response, depend on FDC networks and their immune 
complex display. Because of their close association and interaction with B cells, FDC 
are key players in the initiation and maintenance of anamnestic antibody responses 
and the alteration of their function may contribute to deficits or deficiency in the 
immune responses and development of immune system related-diseases e.g. 
lymphoma, acquired immune-deficiency syndrome (AIDS), transmissible spongiform 
encephalitis (TSE) and autoimmune diseases such as rheumatoid arthritis (Li, Choi, 
2002; Gribben, 2010;  Kosco-Vilbois, 2002; Park, Choi, 2005). Even though FDC 
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frequently feature in the microenvironment of several non-Hodgkin lymphomas, the 
follicular dendritic cell sarcoma is curiously a rare disease with a neoplastic 
proliferation of cells showing morphologic and immunophenotypic features of FDC 
outside of the lymphoid follicles (Swerdlow et al., 2008). 
 
FDC in aging 
It is a well known phenomenon that the specific antibody response decline in aging. 
Because of the crucial role FDC play in the formation of GC, selection and 
differentiation of memory B cells and maintenance of secondary antibody response, 
one might speculate that this phenomenon is also associated with age-related 
changes in FDC networks such as reduced immune complex (IC) presentation. 
However, Aydar et al. has shown that old FDC express near normal levels of Fc 
binding proteins and complement receptors, indicating that the lack of IC presentation 
is not likely attributable to the lack of Fc and complement receptors, but, at least in 
part, to the reduced transport of IC to the FDC reticulum by antigen-presenting cells 
and the reduced ability of old FDC to protect the retained antigen from macrophages 
in comparison with young FDC (Aydar et al., 2002; Szakal et al., 1990, 1992). 
Furthermore, aged FDC produce fewer iccosomes (immune complex-coated bodies) 
for delivery of antigen to B cells for endocytosis, antigen processing and presentation 
to T cells. Moreover, the number of FDC reticula is reduced and the GC size and 
numbers are decreased (Szakal et al., 1990, 1992, 2002). Thus, senescence leads to 
the appearance of atrophic FDC that trap and retain little immune complexes, 
generate few iccosomes and memory B cells and induce a reduced number of GC 
(Aydar et al., 2002). The age-related depression of FDC functions results in the 
paucity of GC in aged individuals characterized by a progressive decline in 
responsiveness to exogenous antigen that may contribute to an increased morbidity 
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and mortality in the elderly (Aydar et al., 2002; Szakal et al., 1990; Szakal et al., 
1992). The methods developed within this project might be useful to adress the 
question of ageing phenotypes of FDC, too. 
 
Methods for FDC detection and characterization 
Although the detection of FDC by immunohistochemical methods is a standard 
procedure in diagnostic hematopathology, FDC remain a challenging cell type due to 
their morphology and phenotypical heterogeneity inside GC. Since FDC are large 
cells with long dendritic extensions and hardly detectable cell bodies, the 
quantification of the extent of FDC networks or the immunophenotype of FDC using 
conventional staining and light microscopy is highly observer-dependent. 
Furthermore, because of their different immunophenotype in the dark and light zone 
of GC, not every monoclonal antibody is reactive for FDC in the entire GC. Gene 
expression profiling studies, which have demonstrated that the expression of genes 
derived from non-lymphoma bystander cells such as dendritic cells might be 
prognostically relevant, is unfortunately not applicable to formalin-fixed, paraffin-
embedded (FFPE) tissue, the medium of choice for most clinical and research due to 
their superior preservation of morphology (Dave et al., 2004; Key, 2006). However, 
quantification of follicular dendritic cells and their protein expression in FFPE tissues 
might not only be important for understanding and classifying malignant lymphomas, 
but also for examining their possible role as prognostic marker and a target for 
immune modulation as well as treatment of B cell tumors of GC origin. Thus, we 
established a method for semiquantitative assessment of the extent of FDC networks 
and of protein expression in FDC employing multicolor immunofluorescence staining 
followed by digital image analysis to detect FDC with its dendritic extensions. We 
applied Ki-M4p, a mouse monoclonal antibody detecting FDC network through the 
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whole of the lymphoid follicle, as pan-FDC marker (Maeda et al, 2002; Parwaresch et 
al., 1983) and antibodies detecting representative functional groups of FDC such as 
Fc fragment-binding proteins (CD23), complement receptors (CD35) and adhesion 
molecules (CD54). In all analyses, the area detected by the marker Ki-M4p was 
larger than the area staining for CD23, CD35 or CD54, indicating that Ki-M4p is 
useful as a pan-FDC marker (Parwaresch et al., 1983). And our method reproduced 
the findings from the published literature with regard to the expression of CD23, 
CD35 and CD43 in the normal GC which showed reduced expression in the dark 
zone (Bagdi et al., 2001; Chang et al., 2003; Yoshida et al., 1993). 
Unfortunately, we were unable to establish reliable staining protocols for other 
important FDC functional groups, BAFF/BLys, Notch ligands and IL-15, membrane-
bound molecules involved in transmitting anti-apoptotic and pro-proliferative signals 
to B cells (Park et al., 2004; Park, Choi, 2005, Yoon et al., 2009). Since the published 
literature on BAFF expression by FDC show unexpected nuclear, instead of 
membrane, staining patterns, we assume that reliable BAFF antibodies for FFPE 
tissues are currently not available (Hase et al., 2004). Because of their involvement 
in mediating the survival and proliferation of GC B cells, possibly also of malignant B 
cells in NHL, future studies will have to focus on evaluating the quantitative 
expression of these proteins on FDC in reactive and neoplastic lymphoid follicles and 
examine whether the functions mediated by them are altered in the FDC found in 
NHL.  
 
FDC in lymphoma and their possible role in lymphomagenesis 
The preferential localization of lymphoma cells in the GC, a dynamic 
microenvironment where antigen-activated B cells expand and undergo events 
associated with antibody maturation, suggests a unique relationship between B cells 
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and their microenvironment (Allen, Cyster, 2008; Küppers et al., 1999; Park, Choi, 
2005). Recent study has shown that the interactions between FDC and GC B cells 
rescue the selected B cell clones from apoptosis (Park, Choi, 2005; Thompson et al., 
2000). Further differentiation of selected B cells toward either plasma cells or 
memory B cells is also dependent on FDC (Allen, Cyster, 2008; El Shikh et al., 2006; 
Park, Choi, 2005). Because of the intimate relationship between FDC and B cells, 
FDC is expected to affect B cells and even play a role in pathogenesis of neoplastic 
lymphoproliferations in yet uncertain way (Bagdi et al., 2001). In certain B cell non-
Hodgkin lymphomas (NHL) FDC can be detected among the reactive bystander cells 
of the tumor (Bagdi et al., 2001). Whereas in marginal zone lymphomas the FDC are 
considered to represent remnants of GC that have been colonized by lymphoma cells, 
it has been suggested that FDC in mantle cell lymphoma (MCL), follicular lymphoma 
(FL) and angioimmunoblastic T cell lymphoma (AITL) are newly generated and have 
proliferated during lymphoma growth and expansion (Swerdlow et al., 2008). 
Structural alteration in the network of FDC such as atypical shape or expansion are 
also frequently found in malignant lymphoma and can be useful adjunct in the 
diagnostic immunophenotyping of the malignant lymphomas (Bagdi et al., 2001). In 
FL the abnormal follicles demonstrate dense, sharply defined and expanded FDC 
networks reminiscent of those seen in the normal germinal centers. They are 
exclusively found within malignant follicles and absent in the interfollicular lymphoma 
compartment as well as in diffusely growing FL (Bagdi et al., 2001; Klapper et al., 
2007). In MCL loosely arranged, weakly developed FDC network in nodular or diffuse 
patterns are observed (Bagdi et al., 2001, Schrader et al., 2006). And the most 
common morphological subtype of AITL (pattern 3) shows a prominent diffuse 
proliferation of FDC network with frequent incorporation of proliferating postcapillary 
venules, an important hallmark of the disease since this pattern has not been found 
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in any other T cell lymphomas hence facilitating the differential diagnosis (Attygalle et 
al., 2002; Bagdi et al., 2001).  
The immunophenotype of FDC in reactive and neoplastic lymphoid tissues has been 
characterized, and reduced expression of markers of mature FDC was noted in FL 
and MCL (Bagdi et al., 2001; Chang et al., 2003). In our study, we were able to 
demonstrate that the expression of all functional markers examined, namely CD23, 
CD35 and CD54, was also reduced in the FDC found in FL, AITL and MCL, 
resembling the FDC of GC dark zone. This suggests that FDC in FL, AITL and MCL 
are not primarily involved in immune complex presentation and selection of B cells 
like the FDC of GC light zone, but their function could take after the function of dark 
zone FDC and provide stimulating factors for B cell proliferation and survival. 
Tsunoda et al. have suggested that FDC networks in FL of grade 1 and 2 may be 
similar to those in the GC light zone and FDC networks in FL of grade 3 to those in 
the dark zone, based on the expression profile of calcium binding proteins, S100 and 
caldesmon (Tsunoda et al., 1999). Our finding, the similar immunophenotype of the 
dark zone FDC in comparison with those in FL, AITL and MCL, is in contrast to this 
earlier report and indicates a closer relation between the FDC in NHL and the dark 
zone FDC in morphology and function. 
 
FDC as prognostic marker in non-Hodgkin lymphomas 
The microenvironment is the compilation of accessory cells that work as a team 
through cell-cell contacts and active molecular crosstalk to provide a functional 
scaffolding to parenchymal cells. It can be instrumental to the survival and 
propagation of malignant cells by producing growth factors, inducing new vessel 
formation for nutrients and immune tolerance to avoid immune-mediated elimination 
(Burger et al., 2009). GC with its special microenvironmental organization comprised 
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of a variety of cell populations, including T cell subsets, macrophages and FDC, 
linked by topographical and functional relationships, is not only the main source of 
immunity against invading microorganisms, but also the main origin of B cell 
lymphomas (Klein, Dalla-Favera, 2008; Küppers et al., 1999). Several gene 
expression profiling studies and immunohistochemical analyses in lymphoma biopsy 
samples have confirmed that the biological behavior and tumor progression may be 
influenced by the tumor microenvironment (Carbone et al., 2009; Dave et al., 2004; 
Glas et al., 2007). Recently, Dave et al. have revealed that the expression of FDC-
related genes is associated with the clinical course in follicular lymphoma (Dave et al., 
2004). Another study has shown that the growth pattern and distribution of FDC in 
mantle cell lymphoma are associated with the clinical outcome (Schrader et al., 
2006). Goven et al. have demonstrated that FDC are able to avoid the spontaneous 
apoptosis of FL malignant B cells preventing the activation of different caspases 
(Goval et al., 2008). All of these findings highlight the role of FDC as accessory cells 
in tumor microenvironment and their influence on malignant cells. 
Follicular lymphoma, the second most frequent NHL in adults worldwide, is an 
indolent lymphoma with a median survival of approximately 10 years following 
diagnosis. However, the clinical course of FL patients is very heterogeneous; some 
patients have an aggressive illness that is fatal in less than one year while others 
may live more than 20 years (Álvaro et al., 2006; Klapper et al., 2007; Staudt, Dave, 
2005). Thus, the identification of prognostic marker would provide useful information 
for deciding on treatment strategies in individual FL patients. In the current work, we 
quantified the extent of FDC networks in the malignant follicles of FL and correlated it 
to the clinical outcome. Although our technique allows an accurate quantification of 
the extent of FDC networks within malignant follicles of FL, we were unable to 
demonstrate an association between the extent of FDC networks and prognosis. 
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However, a simple comparison and cross validation of this research finding with the 
results from gene expression profiling studies are limited since gene expression 
profiling reflects complex biological processes involving multiple cell types whereas 
our immunohistochemcal stainings detect one cell type, namely FDC, only (Dave et 
al., 2004; Staudt, Dave, 2005). Moreover, interactions of T cells with FDC might 
influence the expression of FDC protein, CD23 and thus, also the result of gene 
expression signature (Sukumar et al., 2006). Furthermore, it should be noted that the 
patient selection and end points are essentially different between study groups, 
precluding strong conclusions based on such comparisons (Dave et al., 2004; Glas et 
al., 2007). Finally, we have not assessed the shape of FDC networks and expression 
levels of other important functional groups such as CD35 and CD54 which might also 
be of prognostic relevance (Glas et al., 2007).  
The dependence of the malignant cells on external signals from the 
microenvironment, such as antigens, cytokines and cell-cell interactions, is 
indisputable even though the precise nature of the relevant cell populations and the 
molecular mechanisms involved in lymphoma progression have not yet been clearly 
defined (Dave et al., 2004; Gribben, 2010). The question whether the specific 
lymphoma microenvironment develops by infiltration of accessory cells from outside 
or differentiation of the accessory cells in loco e.g. by stimuli provided by malignant 
cells remain to be solved. Published data on the prognostic significance of cell 
populations, including T cell subsets, macrophages and FDC have produced 
conflicting results. Some of this can be explained by the impact of previous treatment 
on different population of cells within the microenvironment (de Jong et al., 2009; 
Gribben, 2010). In conclusion, the microenvironment plays a crucial role in 
influencing the clinical behavior of malignant B cells and therefore, the development 
and progression of NHL (Burger et al., 2009). It will be a challenge over the coming 
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years to uncover the complex biological processes in the tumor microenvironment. 
Despite the difficulties, future studies using quantitative in situ methods such as the 
one presented here will help us to understand which types of reactive bystander cells 
might be of use as a clinical applicable prognosticator and to develop intelligent 
treatment strategies targeted to specific biologic mechanisms responsible for the 
disease progression such as FL. 
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5 Summary 
 
 
Follicular dendritic cells represent a unique population of specialized antigen-
presenting cells found in the primary and secondary lymphoid follicles under reactive 
conditions and in certain non-Hodgkin lymphomas among the reactive bystander 
cells of tumor (Allen, Cyster, 2008; Park, Choi, 2005). Follicular dendritic cells form a 
three-dimensional network to sustain the architecture of germinal center and play a 
pivotal role in the selection of antigen-specific B cells and their clonal expansion in 
the germinal center (Allen, Cyster, 2008; Park, Choi, 2005).  
Recently, several gene expression profiling studies and immunohistochemical 
analyses in lymphoma biopsy samples have revealed that follicular dendritic cell 
networks might be associated with the clinical outcome in certain non-Hodgkin 
lymphomas (Carbone et al., 2009; Dave et al., 2004; Glas et al., 2007). We therefore 
determined semiquantitatively the extent and the immunophenotype of follicular 
dendritic cells in both reactive germinal centers and non-Hodgkin lymphomas, 
namely follicular lymphoma, angioimmunoblastic T cell lymphoma and mantle cell 
lymphoma, using fluorescent double staining followed by digital image analysis.  
In all tested non-Hodgkin lymphomas, proteins that are involved in the antigen-
dependent interaction of follicular dendritic cells and B cells, such as CD23 and 
CD35, and in adhesion, such as CD54, were expressed at relatively low levels on 
follicular dendritic cells, comparable to follicular dendritic cells found in the dark zone 
of the germinal center, suggesting functional and phenotypical heterogeneity of 
follicular dendritic cells in germinal centers and non-Hodgkin lymphomas. However, 
there was no association between the extent of follicular dendritic cell networks with 
the clinical outcome of 102 patients with follicular lymphoma treated within a 
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prospectively randomized trial as measured by time to treatment failure or overall 
survival.  
In summary, follicular dendritic cells found in different types of non-Hodgkin 
lymphomas show quantitatively reduced expression of several proteins, suggesting 
that there are functional differences between follicular dendritic cells in normal 
germinal centers and non-Hodgkin lymphomas. The extent of the follicular dendritic 
cell networks in follicular lymphoma, however, is not useful as a prognostic marker. 
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6 Appendix 
 
 
Legends of figures and tables 
Figure 1: Interaction between FDC and GC B cell. FDC interact with GC B cells via 
several mechanisms including adhesion molecules such as ICAM-1 and VCAM-1, B 
cell anti-apoptotic TNF superfamily ligand BAFF, Fc binding proteins such as CD23 
and complement receptors such as CD 21 for immune complex presentation and 8D6 
and membrane-bound interleukin (IL)-15 for B cell proliferation. 
Figure 2: Representative examples of fluorescent double staining using the pan-FDC 
marker Ki-M4p (A, single staining), CD23 (B, single staining), Ki-M4p and CD23 (C, 
double staining) and quantitative image analysis “Phase analysis” (D) with software 
analySIS to assess the extent of co-expression. 
Figure 3: Representative example of fluorescence double staining using the pan-
FDC marker Ki-M4p (green) and CD23 (red) in a reactive germinal center (GC). In 
the light zone (LZ), FDC are present in a much higher density than in the dark zone 
(DZ). 
Figure 4: Quantitative analysis of co-expression of CD23, CD35 and CD54 on 
follicular dendritic cells (FDC) in the entire germinal center (total GC) or the dark zone 
(DZ) in tonsils. The FDC in the dark zone (DZ) of the GC display a reduced 
expression of the Fc-receptor (CD23), complement receptor 1 (CD35) and adhesion 
molecule ICAM-1 (CD54), compared to the FDC in the whole follicle (total GC), which 
is dominated by the light zone FDC. P-values were obtained using t-tests. Horizontal 
bars indicate the mean. 
Figure 5: Quantitative analysis of co-expression of CD23 (A), CD35 (B) and CD54 
(C) on FDC in the entire germinal center (total GC), follicular lymphoma (FL), 
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angioimmunoblastic T-cell lymphoma (AITL) and mantle cell lymphoma (MCL). FDC 
in FL, AITL and MCL display quantitatively reduced expression of CD23, CD35 and 
CD54 compared to the FDC in the whole GC. The levels of CD35 and CD54 co-
expression in the lymphomas are comparable with the FDC in the dark zone of the 
GC (P-values not significant using a t-test, data shown in Table 8). P-values were 
obtained using t-tests. Horizontal bars indicate the mean. 
Figure 6: Representative examples of fluorescence double staining using the pan-
FDC marker Ki-M4p (green) and co-expression (yellow) of CD23 (red), CD35 (red) 
and CD54 (red) in representative examples of follicular lymphoma (FL), 
angioimmunoblastic T cell lymphoma (AITL) and mantle cell lymphoma (MCL). 
 
Table 1: Clinical baseline characteristics of the population studied in this report (n = 
137) compared with all patients with advanced stage follicular lymphoma registered 
in the trial (n = 538). 
Table 2: Antibodies and their sources 
Table 3: Buffers, solutions and fabrication formula 
Table 4: Chemicals and their sources 
Table 5: Utensils and their sources 
Table 6: Software and their sources 
Table 7: Co-expression on FDC. All values as % co-expressing FDC area. GC = 
germinal center, DZ = dark zone, SD = standard deviation. 
Table 8: Co-expression on FDC. All values as % co-expressing FDC area. GC = 
germinal center, DZ = dark zone, FL = follicular lymphoma, AITL = 
angioimmunoblastic T cell lymphoma, MCL = mantle cell lymphoma, SD = standard 
deviation. 
Table 9: Prognostic relevance of the extent of FDC networks in malignant follicles of 
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follicular lymphoma. There was no association between the extent of the FDC 
networks measured by Ki-M4p or CD23 with clinical outcome, as measured by time-
to-treatment failure (TTF) (A) and overall survival (OS) (B) estimated by univariate 
and adjusted Cox regression model. 
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